Panacell Biotech is a global biotechnology company leading the world's advanced regenerative medicine and biopharmaceutical medicine sectors.
Our best-in-class regenerative medicine's breakthrough biotechnology helps kill cancer cells by activating immune cells, and treat various diseases and incurable diseases by culturing stem cells. This technology can also be used for hair loss treatment and skincare. Focusing on research and development, Panacell Biotech invites global biotechnology experts to provide the best regenerative medical services to customers
Panacell Biotech provides One-Stop Service from cell storage to cell culture and treatment with excellent own technology.
The best-in-class regenerative medicine breakthrough biotechnology is used to activate immune cells, kill cancer cells, cultivate stem cells, treat many diseases and incurable diseases, and also treat hair loss and skin care.
Panacell Biotech Co., Ltd., a company specializing in the research of cellular immunotherapeutics that has obtained the certification of a licensed company for cell processing facilities from the Ministry of Food and Drug Safety, was approved by ISO (International Organization for Standardization) on July 22, 2022 as:
Service quality management (ISO 9001) and environmental management (ISO 14001) system certification company
Thank you infinitely for your trust and support for Panacell Biotech Co., Ltd. and promise to do our best in active communication and customer service in the future.
A world where everyone in the world lives healthy and beautiful is no longer just a dream. Recently, we humans are getting answers in the field of cell therapy using stem cells and immune cells. We define advanced regenerative medicine by encompassing the latest medical fields including cell therapy.
Advanced regenerative medicine is an innovative field of medical technology that can treat many rare and incurable diseases that were considered impossible in the past. You could call it medical technology. When we benefit from advanced regenerative medical technology, we can activate immune cells to remove cancer cells, cultivate stem cells to treat various diseases, incurable and incurable diseases, and can also be used for hair loss treatment and skin care.
It opens up groundbreaking possibilities for many diseases that previously had no cure and had to be abandoned. In advanced regenerative medicine with such epoch-making potential, several overseas countries have already established an institutional foundation and have taken the lead in research and development and clinical application. In Korea, an institutional framework for advanced regenerative medicine was not prepared due to a somewhat prudent legal approach, resulting in restrictions on related R&D tasks. There were many cases of receiving treatment or giving up treatment.
As the need to improve these various problems expanded, Korea finally enacted the 'Act on Safety and Support for Advanced Regenerative Medicine and Advanced Biopharmaceuticals' in August 2019, and from 2021 to 2025, K-Regenerative Medicine (Korea- Advanced Regenerative Medicine), the first five-year master plan was established. Panacell Biotech Co., Ltd. was established with the goal of becoming a global company leading the world's advanced regenerative medicine and advanced biopharmaceuticals in line with the current domestic and international trends.
As the CEO of Panacell Biotech Co., Ltd, and as a specialist who has treated numerous patients on the frontline of medical care, I am committed to contributing to the health of more people and leading a new era through groundbreaking biotechnology in the field of advanced regenerative medicine, will go into management. In addition, the executives and employees of Panacell Biotech Co., Ltd., each possessing world-class capabilities in each field, fulfill their responsibilities and roles with a firm vision to contribute to realizing a healthier and more beautiful life for mankind, developing Panacell Biotech Co., Ltd. into a world-class company. We will do it. We will do our best to fulfill our role by strengthening our professionalism through ceaseless efforts.
Choi Seung-ho, CEO of Panacell Biotech Co., Ltd.
Council
Chairman
Supervision
Advisory Group/
Advisory Board
CTO
Enterprise Research Center
Manufacturing Sector
Clinical Department
Operate Department
CMOs
CROs
Knowledge patent
Financial support
Strategic planning
Address:521, Teheran-ro, Gangnam-gu, Seoul, Republic of Korea
Telephone:02-532-2856
E-mail:info@panacellbio.com